Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Propranolol

Adrenergic receptor inhibitor
 
BML-ST405-0005 5 g 62.00 USD
Do you need bulk/larger quantities?
 
Propranolol blocks PLD derived DAG formation by inhibiting phosphatidate phosphohydrolase (IC50=70 µM). It is a useful tool to discriminate between PLC or PLD mediated DAG production. It is also a β-adrenergic receptor blocking agent.

Product Specification

Formula:C16H21NO2 . HCl
 
MW:295.8
 
CAS:318-98-9
 
Purity:≥98% (HPLC)
 
Identity:Determined by 1H-NMR and LC-MS.
 
Appearance:White to off-white powder.
 
Solubility:Soluble in water.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 
ST405 Propranolol
Please mouse over
ST405 Propranolol

Product Literature References

New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators: X. Sun, et al.; Cell Cycle 14, 721 (2015), Abstract; Full Text
Receptor-coupled phospholipase D and its inhibition: N.T. Thompson, et al.; Trends Pharmacol. Sci. 12, 404 (1991), Abstract;
Regulation of phospholipase D in HL-60 granulocytes. Activation by phorbol esters, diglyceride, and calcium ionophore via protein kinase- independent mechanisms: M. M. Billah, et al.; J. Biol. Chem. 264, 9069 (1989), Abstract; Full Text
The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias: A. M. Barrett, et al.; Br. J. Pharmacol. 34, 43 (1968), Abstract; Full Text

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

 
Keep in touch

©2020 Enzo Life Sciences, Inc.,